Governments and health agencies should reconsider the current guidelines with regards to widespread mask use in the COVID-19 pandemic and recommend that masks be worn by everyone, argue a team of researchers at the University of Cambridge
A new test for infection with SARS-CoV2 that which inactivates the virus at the point of sampling, has been developed by a team of researchers at the Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID). It is now being used to test and screen frontline NHS staff at a Cambridge hospital.
Researchers have designed bionic 3D-printed corals that could help energy production and coral reef research.
On Monday, 265 final year medical students from the University of Cambridge graduated early, allowing them to seek early registration with the General Medical Council (GMC) and enter the NHS workforce before their expected date in August.
Study charts the 'incipient supernova' of SARS-CoV-2 through genetic mutations as it spread from China and Asia to Australia, Europe and North America. Researchers say their methods could be used to help identify undocumented infection sources.
One of Cambridge’s newest institutes, established to study the relationship between infectious disease and our immune systems, is leading the University of Cambridge’s response to the COVID-19 pandemic, with over 150 scientists and clinicians, the UK’s largest academic Containment Level 3 Facility, and a range of collaborators from across the UK and beyond.
An online tool to illustrate the effects of different COVID-19 control measures has been developed by a team of University of Cambridge researchers.
Professor Julia Gog is a mathematician who specialises in modelling the spread of infectious diseases, particularly pandemic influenza. For months, she and the other members of her research group in the Department of Applied Mathematics and Theoretical Physics have been modelling and mapping the spread of coronavirus and COVID-19.
As part of the UK Government’s announcement of a new five pillar plan to boost testing for COVID-19, AstraZeneca, GSK and the University of Cambridge have formed a joint collaboration to take action to support this national effort.
Modelling tools originally designed to improve the efficiency of factories are being used by Cambridge engineers to help Addenbrooke’s Hospital manage the COVID-19 emergency.
© 2025 University of Cambridge